Calvo Carlos Ignacio, Fender Kai, Hoy Nathan, Rourke Keith
Division of Urology, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
Departamento de Urología, Pontificia Universidad Católica de Chile, Santiago, Chile.
J Urol. 2024 Mar;211(3):455-464. doi: 10.1097/JU.0000000000003826. Epub 2023 Dec 18.
There is a paucity of reported long-term outcomes after contemporary urethroplasty. Our objective is to determine the long-term success of modern urethroplasty and identify factors associated with stricture recurrence in this context.
Patients undergoing urethroplasty from July 2003 to May 2013 with at least 100 months of follow-up were identified. Long-term outcomes including stricture recurrence and patient satisfaction were evaluated by review of regional/provincial electronic records and telephone interview. Urethroplasty failure was defined as a recurrent stricture (<16F) confirmed on cystoscopy. Cox regression was used to evaluate variables associated with long-term stricture recurrence.
A total of 733 patients were identified with ≥ 100 months follow-up. Median patient age was 45 years, stricture length was 4.7 cm, and 85.8% failed prior endoscopic treatment. At a median follow-up of 12.3 years, 89 recurrences were observed. Cumulative incidence of stricture recurrence was 6%, 10%, and 12% after 1, 5, and 10 years, respectively. From a patient-reported perspective, 89% of patients reported being satisfied with the outcome of surgery. On multivariable analyses, increasing stricture length (HR 1.1, 95% CI 1.05-1.15; < .001) and stricture etiology ( < .001), in particular lichen sclerosus (HR 4.46, 95% CI 2.25-9.53), radiation (HR 4.25, 95% CI 1.65-10.9), and infectious strictures (HR 5.27, 95% CI 2.03-13.7), were independently associated with stricture recurrence.
This study affirms the widely held belief that modern urethroplasty provides high long-term patency and patient-reported satisfaction. Patients with longer strictures as well as those with lichen sclerosus, radiation, and infectious etiologies have a higher hazard of stricture recurrence in the long term.
当代尿道成形术后长期疗效的报道较少。我们的目的是确定现代尿道成形术的长期成功率,并确定在此背景下与狭窄复发相关的因素。
确定2003年7月至2013年5月接受尿道成形术且随访至少100个月的患者。通过查阅地区/省级电子记录和电话访谈来评估包括狭窄复发和患者满意度在内的长期疗效。尿道成形术失败定义为膀胱镜检查确诊为复发性狭窄(<16F)。采用Cox回归评估与长期狭窄复发相关的变量。
共确定733例患者随访时间≥100个月。患者中位年龄为45岁,狭窄长度为4.7 cm,85.8%的患者既往内镜治疗失败。中位随访12.3年时,观察到89例复发。狭窄复发的累积发生率在1年、5年和10年后分别为6%、10%和12%。从患者报告的角度来看,89%的患者报告对手术结果满意。多变量分析显示,狭窄长度增加(HR 1.1,95%CI 1.05 - 1.15;P <.001)和狭窄病因(P <.001),特别是硬化性苔藓(HR 4.46,95%CI 2.25 - 9.53)、放疗(HR 4.25,95%CI 1.65 - 10.9)和感染性狭窄(HR 5.27,95%CI 2.03 - 13.7)与狭窄复发独立相关。
本研究证实了广泛持有的观点,即现代尿道成形术提供了较高的长期通畅率和患者报告的满意度。狭窄较长以及患有硬化性苔藓、放疗和感染性病因的患者长期狭窄复发风险较高。